NasdaqGM - Nasdaq Real Time Price USD

Corvus Pharmaceuticals, Inc. (CRVS)

4.5000
+0.2500
+(5.88%)
At close: 4:00:01 PM EDT
4.5800
+0.08
+(1.78%)
After hours: 7:06:20 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-28,530
-25,424
-23,935
-27,023
-36,715
Investing Cash Flow
-23,234
-27,484
15,541
-23,276
21,560
Financing Cash Flow
49,307
49,028
7,855
0
62,158
End Cash Position
4,999
8,740
12,620
13,159
63,458
Capital Expenditure
--
--
-34
-269
-5
Issuance of Capital Stock
--
16,405
7,843
0
60,943
Free Cash Flow
-28,566
-25,424
-23,969
-27,292
-36,720
12/31/2021 - 3/23/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LPTX Leap Therapeutics, Inc.
0.4359
+4.36%
 
LXEO Lexeo Therapeutics, Inc.
4.5100
-2.17%
 
TRVI Trevi Therapeutics, Inc.
6.25
-3.99%
 
ELEV Elevation Oncology, Inc.
0.3795
-0.84%
 
KYMR Kymera Therapeutics, Inc.
48.39
-0.43%
 
CTMX CytomX Therapeutics, Inc.
2.8200
+4.44%
 
AKRO Akero Therapeutics, Inc.
52.96
-2.87%
 
KROS Keros Therapeutics, Inc.
13.79
+0.29%
 
PTGX Protagonist Therapeutics, Inc.
55.34
-1.83%
 
CLSD Clearside Biomedical, Inc.
0.8081
-0.23%